Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
349 studies found for:    metabolic syndrome AND syndrome X AND insulin resistance AND diabetes
Show Display Options
Rank Status Study
21 Active, not recruiting
Has Results
Oral Contraceptives in the Metabolic Syndrome
Conditions: Metabolic Syndrome X;   Insulin Resistance;   Obesity;   Cardiovascular Diseases
Intervention: Drug: Ortho Tri Cyclen
22 Active, not recruiting Chloroquine to Treat People With Metabolic Syndrome Aim2 (ARCH-MS)
Conditions: Metabolic Syndrome X;   Overweight;   Hypertension;   Dyslipidemias;   Prediabetic State
Interventions: Drug: Placebo Comparator Limb 1;   Drug: Chloroquine
23 Active, not recruiting LUPS-Lipids and Glucose Under Prospective Surveillance
Conditions: Metabolic Syndrome, Syndrome X, MetS,;   Diabetes Mellitus, Non-Insulin-Dependent
Intervention:
24 Unknown  Metabolic Syndrome and Insulin Resistance at Allina
Condition: Metabolic Syndrome
Intervention: Dietary Supplement: vitamin D3 (cholecalciferol)
25 Recruiting Weight Loss Program to Prevent Heart Disease
Conditions: Insulin Resistance,;   Metabolic Syndrome;   Type 2 Diabetes
Intervention: Behavioral: PilAm Go4Health Weight-loss Program
26 Recruiting Resveratrol and the Metabolic Syndrome
Conditions: Obesity;   Insulin Resistance;   Metabolic Syndrome
Interventions: Dietary Supplement: Placebo;   Dietary Supplement: Resveratrol
27 Completed Effects of Chromium Supplementation on Parameters of the Metabolic Syndrome in Patients With Type 2 Diabetes Mellitus
Condition: Diabetes Mellitus, Type 2
Intervention: Drug: Baker’s yeast (Bio Chromium)
28 Completed Probiotic Bacteria in Prevention of the Metabolic Syndrome
Condition: Metabolic Syndrome X
Interventions: Dietary Supplement: Lactobacillus plantarum PCS 26;   Dietary Supplement: Placebo
29 Completed Integrating Lifestyle Therapy for Diabetes Prevention Into Primary Care
Conditions: Pre-Diabetes;   Metabolic Syndrome;   Type 2 Diabetes
Intervention: Behavioral: Lifestyle intervention and provider feedback
30 Completed A Phase IIa Proof-of-concept Study of NC-503 in Patients With Type II Diabetes
Conditions: Diabetes Mellitus, Type 2;   Metabolic Syndrome X
Interventions: Drug: NC-503 (eprodisate disodium);   Other: placebo
31 Completed Mechanism of Fatty Acid-Induced Impairment of Glucose-Stimulated Insulin Secretion
Conditions: Insulin Resistance Syndrome X;   Pancreatic Beta Cell Function
Intervention: Drug: N-acetylcysteine, intralipid, heparin
32 Unknown  The Roles of Cytokines in the Mechanism of Insulin Resistance and Energy Balance
Conditions: Metabolic Syndrome X;   Cachexia;   Insulin Resistance
Intervention:
33 Recruiting Role of Growth Hormone Antagonism in Modulating Insulin Sensitivity in Subjects With Pre-diabetes
Conditions: Diabetes;   Metabolic Syndrome;   Insulin Resistance
Intervention: Drug: pegvisomant
34 Unknown  Side Effects of Antipsychotic Medications
Conditions: Insulin Resistance;   Metabolic Syndrome X;   Schizophrenia and Disorders With Psychotic Features;   Mood Disorders;   Psychotic Disorders
Intervention:
35 Recruiting Metformin in the Diastolic Dysfunction of Metabolic Syndrome
Conditions: Metabolic Syndrome X;   Diastolic Dysfunction;   Insulin Resistance
Interventions: Behavioral: Lifestyle Counseling;   Drug: Metformin
36 Completed The Effect of Nordic Recommended Diet on the Features of Metabolic Syndrome - Multicentre Study
Conditions: Abdominal Obesity;   Insulin Resistance;   Impaired Glucose Tolerance;   Type 2 Diabetes;   Cardiovascular Diseases
Interventions: Other: Experimental diet;   Other: Control diet
37 Completed Efficacy of a Prebiotic Galactooligosaccharide to Reduce Metabolic Syndrome Risk Factors in Overweight Adults
Condition: Metabolic Syndrome X
Interventions: Dietary Supplement: Bimuno;   Dietary Supplement: Maltodextrin
38 Completed Microcirculation Assessment in Diabetes and Metabolic Syndrome
Conditions: Coronary Microvascular Dysfunction;   Metabolic Syndrome;   Diabetes
Intervention: Other: Coronary microcirculation assessment
39 Completed Effect Of Rosiglitazone On Carotid Intima Media Thickness In Patients With Insulin Resistance Syndrome And/Or Type 2 Diabetes
Condition: Non-Insulin-Dependent Diabetes Mellitus
Intervention: Drug: Rosiglitazone
40 Unknown  Randomized Comparison of Laparoscopic Sleeve Gastrectomy and Gastric Bypass for Morbid Obesity
Conditions: Morbid Obesity;   Metabolic Syndrome X;   Diabetes Mellitus;   Dyslipidemia;   Hypertension
Interventions: Procedure: Laparoscopic sleeve gastrectomy;   Procedure: Roux-en-Y Gastric Bypass

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years